D(
Therapeutic Areas
Piramal Pharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| CDMO Client Portfolio | Various (Oncology, CNS, Metabolic, Infectious Disease) | Various |
| Complex Generic Injectables Portfolio | Critical Care, Anesthesia, Pain Management, Oncology Support | Approved |
| Propofol | Anesthesia | Approved |
| Sevoflurane | Anesthesia | Approved |
| Fentanyl | Pain Management | Approved |
Leadership Team at Piramal Pharma
NP
Nandini Piramal
Executive Chairperson
PD
Peter DeYoung
Chief Executive Officer
RG
Rahul Guha
Chief Financial Officer
VS
Vijay Shah
Chief Operating Officer
KS
Kunal Saxena
Chief Business Officer, CDMO
SS
Sudeep Singh
Chief Business Officer, India Consumer Products Division
AM
Ashwin Muralidharan
Chief Business Officer, Complex Hospital Generics
DS
Dr. Swati Piramal
Vice Chairperson
VG
Vijayendra G. Lele
Independent Director
SR
Suneeta Reddy
Independent Director